Sinocare Completes Acquisition of PTS Diagnostics | 合法醫療器材資訊網

PTSDiagnosticswillcontinuetomanufacture&marketfast,easyandaccuratediagnosticsdevicesthattestandscreenforheartdisease,diabetesand...

INDIANAPOLIS, July 21, 2016 (GLOBE NEWSWIRE) -- PTS Diagnostics, the US-based manufacturer of point-of-care biometric testing devices, has been acquired by Sinocare, a biosensor technology company that enables both medical professionals and individuals across the globe to identify, monitor and diagnose chronic diseases at the point of care.

Sinocare paid $110 million in cash for PTS Diagnostics with additional contingent consideration of up to $90 million upon the successful accomplishment of certain milestones over the next 18 months.

PTS Diagnostics will continue to manufacture in the United States and market globally its signature products including the CardioChek® family of lipid analyzers, A1CNow® systems and PTS Detect™ cotinine systems.  In addition, the company is actively marketing its PTS Connect™ solution, a connectivity and information management platf...